993 research outputs found

    Development of the Magnetic Excitations of Charge-Stripe Ordered La(2-x)Sr(x)NiO(4) on Doping Towards Checkerboard Charge Order

    Get PDF
    The magnetic excitation spectrums of charge stripe ordered La(2-x)Sr(x)NiO(4) x = 0.45 and x = 0.4 were studied by inelastic neutron scattering. We found the magnetic excitation spectrum of x = 0.45 from the ordered Ni^2+ S = 1 spins to match that of checkerboard charge ordered La(1.5)Sr(0.5)NiO(4). The distinctive asymmetry in the magnetic excitations above 40 meV was observed for both doping levels, but an additional ferromagnetic mode was observed in x = 0.45 and not in the x = 0.4. We discuss the origin of crossover in the excitation spectrum between x = 0.45 and x = 0.4 with respect to discommensurations in the charge stripe structure.Comment: 4 Figures. To be appear in the J. Kor. Phys. Soc. as a proceedings paper from the ICM 2012 conferenc

    Study of Comparative Negligence

    Get PDF

    Investigation of the collapse of the skewness and kurtosis exhibited in atmospheric dispersion data

    Get PDF
    This paper studies the collapse of the estimators for skewness and kurtosis of concentration onto a near universal curve. This phenomenon is observed for data taken from atmospheric dispersion experiments under a variety of different conditions. By means of careful investigation of the high concentration tails, modelled by means of the generalized Pareto distribution, and the fundamental physics of the problem, a set of envelope curves encompassing the data will be established. The implications of these results for modelling the probability density function of concentration are discussed

    Comments on the properties and uses of atmospheric dispersion datasets

    Get PDF
    Great recent improvements in the quality and quantity of atmospheric dispersion datasets have highlighted the crucial importance of concentration fluctuations. However, this has inevitably been accompanied by the realisation that estimating the properties of concentration fluctuations accurately involves new, difficult, but interesting, research problems. Some of these problems are discussed and illustrated. The paper concludes with some recommendations about how research funding agencies (such as governments, regulatory authorities and industry) should change their present strategy in response to new knowledge

    Two Ising-like magnetic excitations in a single-layer cuprate superconductor

    Full text link
    There exists increasing evidence that the phase diagram of the high-transition temperature (Tc) cuprate superconductors is controlled by a quantum critical point. One distinct theoretical proposal is that, with decreasing hole-carrier concentration, a transition occurs to an ordered state with two circulating orbital currents per CuO2 square. Below the 'pseudogap' temperature T* (T* > Tc), the theory predicts a discrete order parameter and two weakly-dispersive magnetic excitations in structurally simple compounds that should be measurable by neutron scattering. Indeed, novel magnetic order and one such excitation were recently observed. Here, we demonstrate for tetragonal HgBa2CuO4+d the existence of a second excitation with local character, consistent with the theory. The excitations mix with conventional antiferromagnetic fluctuations, which points toward a unifying picture of magnetism in the cuprates that will likely require a multi-band description.Comment: Including supplementary informatio

    Cognitive decline heralds onset of symptomatic inherited prion disease

    Get PDF
    The clinical effectiveness of any disease-modifying treatment for prion disease, as for other neurodegenerative disorders, will depend on early treatment before damage to neural tissue is irrevocable. Thus, there is a need to identify markers that predict disease onset in healthy at-risk individuals. Whilst imaging and neurophysiological biomarkers have shown limited use in this regard, we recently reported progressive neurophysiological changes in individuals with the inherited prion disease mutation P102L. We have also previously demonstrated a signature pattern of fronto-parietal dysfunction in mild prion disease. Here we address whether these cognitive features anticipate the onset of symptoms in a unique sample of patients with inherited prion disease. In the cross-sectional analysis, we analysed the performance of patients at three time points in the course of disease onset: prior to symptoms (n = 27), onset of subjective symptoms without positive clinical findings (n = 8) and symptomatic with positive clinical findings (n = 24). In the longitudinal analysis, we analysed data from 24 patients who were presymptomatic at the time of recruitment and were followed up over a period of up to 17 years, of whom 16 remained healthy and eight converted to become symptomatic. In the cross-sectional analysis, the key finding was that, relative to a group of 25 healthy non-gene carrier controls, patients with subjective symptoms but without positive clinical findings were impaired on a smaller but similar set of tests (Trail Making Test part A, Stroop test, Performance IQ, gesture repetition, figure recall) to those previously found to be impaired in mild prion disease. In the longitudinal analysis, Trail Making Test parts A and B, Stroop test and Performance IQ scores significantly discriminated between patients who remained presymptomatic and those who converted, even before the converters reached criteria for formal diagnosis. Notably, performance on the Stroop test significantly discriminated between presymptomatic patients and converters before the onset of clinical symptoms [area under the curve = 0.83 (95% confidence interval, 0.62–1.00), P = 0.009]. Thus, we report here, for the first time, neuropsychological abnormalities in healthy patients prior to either symptom onset or clinical diagnosis of inherited prion disease. This constitutes an important component of an evolving profile of clinical and biomarker abnormalities in this crucial group for preventive medicine

    Modelling and Analysis of Geocell Reinforced Foundations

    Get PDF
    Geosynthetics, in the form of three dimensional geocell mattresses has emerged as a promising technique to improve the performance of foundations. This study pertains to the development of a mathematical formulation to predict the behaviour of footings (Strip and Circular footings) resting on geocell reinforced granular layer overlying soft soil. To obtain the approximate behaviour of the geocell reinforced system contact pressure distribution of the geocell reinforced bed was considered. The approach based on contact pressure distribution is demonstrative in understanding the pattern of bearing capacity improvement but for exact predictions of the same, numerical investigations using foundation models or experimental studies have to be conducted. Pasternak model was used to represent the geocell reinforced-footing system as it considers the material properties of geocell - subsoil system. Linear and nonlinear responses were considered to account for the behaviour at low and high settlements respectively. The predictions of the Pasternak model were found to hold good for lower range of settlements. The necessity of improvement of the model was understood since Pasternak model doesn’t account for the confining stresses that act on the geocell system from which it derives its major strength. Hence, the stress dependent behaviour was also analyzed later in the research to fully understand the behaviour of geocell reinforced systems. To check the efficiency and applicability of the proposed models the results were validated in several ways (Theoretical, numerical, experimental validation) which indicated good agreement

    Cognitive decline heralds onset of symptomatic inherited prion disease

    Get PDF
    The clinical effectiveness of any disease-modifying treatment for prion disease, as for other neurodegenerative disorders, will depend on early treatment before damage to neural tissue is irrevocable. Thus, there is a need to identify markers which predict disease onset in healthy at-risk individuals. Whilst imaging and neurophysiological biomarkers have shown limited use in this regard, we recently reported progressive neurophysiological changes in healthy people with the inherited prion disease mutation P102L (Rudge et al, Brain 2019). We have also previously demonstrated a signature pattern of fronto-parietal dysfunction in mild prion disease (Caine et al., 2015; 2018). Here we address whether these cognitive features anticipate the onset of symptoms in a unique sample of patients with inherited prion disease. In the cross-sectional analysis, we analysed the performance of patients at three time points in the course of disease onset: prior to symptoms (n = 27), onset of subjective symptoms without positive clinical findings (n = 8) and symptomatic with positive clinical findings (n = 24). In the longitudinal analysis, we analysed data from twenty four patients who were presymptomatic at the time of recruitment and were followed up over a period of up to seventeen years, of whom sixteen remained healthy and eight converted to become symptomatic. In the cross-sectional analysis, the key finding was that, relative to a group of 25 healthy non-gene carrier controls, patients with subjective symptoms but without positive clinical findings were impaired on a smaller but very similar set of tests (Trail Making Test part A, Stroop Test, Performance IQ, gesture repetition, figure recall) to those previously found to be impaired in mild prion disease (Caine et al., 2015; 2018). In the longitudinal analysis, Trail Making Test parts A and B, Stroop test and Performance IQ scores significantly discriminated between patients who remained presymptomatic and those who converted, even before the converters reached criteria for formal diagnosis. Notably, performance on the Stroop test significantly discriminated between presymptomatic patients and converters before the onset of clinical symptoms (AUC = .83 (95% CI, 0.62-1.00), p =.009). Thus, we report here, for the first time, neuropsychological abnormalities in healthy patients prior to either symptom onset or clinical diagnosis of IPD. This constitutes an important component of an evolving profile of clinical and biomarker abnormalities in this crucial group for preventive medicine
    corecore